scispace - formally typeset
N

Nigel J. Clarke

Researcher at Quest Diagnostics

Publications -  115
Citations -  3262

Nigel J. Clarke is an academic researcher from Quest Diagnostics. The author has contributed to research in topics: Mass spectrometry & Metabolite. The author has an hindex of 30, co-authored 112 publications receiving 2784 citations. Previous affiliations of Nigel J. Clarke include Samsung & University of Waterloo.

Papers
More filters
Journal ArticleDOI

Resilient 3D hierarchical architected metamaterials

TL;DR: It is shown, through a combination of experiments and computations, that introducing hierarchy into the architecture of 3D structural metamaterials enables the attainment of a unique combination of properties: ultralightweight, recoverability, and a near-linear scaling of stiffness and strength with density.
Journal ArticleDOI

Advantages and challenges of mass spectrometry assays for steroid hormones

TL;DR: The present review discusses the advantages of MS assays over conventional RIAs and direct immunoassays in steroid hormone measurements, and points out some of the important challenges facing the rapid increase in usage of MS Assays.
Journal ArticleDOI

Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry–Based Assays

TL;DR: The Clinical Proteomic Tumor Analysis Consortium of the National Cancer Institute has collaborated with clinical laboratorians, peptide manufacturers, metrologists, representatives of the pharmaceutical industry, and other professionals to develop a consensus set of recommendations for peptide procurement, characterization, storage, and handling.
Journal ArticleDOI

Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges.

TL;DR: Male and female adult and pediatric reference ranges were developed for this very sensitive and accurate high-throughput LC-MS/MS method, suitable for measuring the expected low-testosterone concentrations seen in women, children, and hypogonadal males and for monitoring testosterone suppressive therapy in prostate cancer patients.